During the past decade, Ophthalmologic Hospital of Qingdao conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ophthalmologic Hospital of Qingdao" #1 collaborator was "University of Wisconsin, Madison" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Ophthalmologic Hospital of Qingdao" are "Choroid Neovascularization Secondary to Degenerative Myopia" (1 trials) and "Neovascular Age-related Macular Degeneration" (1 trials). Many other conditions were trialed in "Ophthalmologic Hospital of Qingdao" in a lesser frequency.

Most popular intervention types in "Ophthalmologic Hospital of Qingdao" are "Biological" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Recombinant Human VEGF Receptor-Fc Fusion Protein" (1 trials), "conbercept, Fixed" (1 trials), "conbercept, PRN" (1 trials) and "sham injection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ophthalmologic Hospital of Qingdao" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Ophthalmologic Hospital of Qingdao". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Ophthalmologic Hospital of Qingdao, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ophthalmologic Hospital of Qingdao, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".